ACB

Aurora Cannabis

4.49 USD
-0.20
4.26%
At close Jul 11, 4:00 PM EDT
After hours
4.50
+0.01
0.22%
1 day
-4.26%
5 days
-0.88%
1 month
-25.66%
3 months
4.91%
6 months
11.41%
Year to date
-0.22%
1 year
-26.63%
5 years
-96.28%
10 years
-99.51%
 

About: Aurora Cannabis Inc headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company operates in Canada, it has expanded internationally through medical cannabis exporting agreements. The company opertes in Canada, Europe, Australia, and Others, with majority revenue from Canada.

Employees: 1,101

0
Funds holding %
of 7,312 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

106% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 18

67% more capital invested

Capital invested by funds: $20.6M [Q4 2024] → $34.5M (+$13.8M) [Q1 2025]

5.49% more ownership

Funds ownership: 8.84% [Q4 2024] → 14.33% (+5.49%) [Q1 2025]

3% less call options, than puts

Call options by funds: $4.19M | Put options by funds: $4.32M

6% less funds holding

Funds holding: 165 [Q4 2024] → 155 (-10) [Q1 2025]

21% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 29

Research analyst outlook

We haven’t received any recent analyst ratings for ACB.

Financial journalist opinion

Based on 22 articles about ACB published over the past 30 days

Positive
MarijuanaStocks
2 days ago
Aurora Cannabis Inc. (ACB) Announces Filing and Mailing of the Management Information
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce that the management information circular (the “Circular”) for the upcoming annual general and special meeting of shareholders is now available on the Company's website at www.auroramj.com/investors/corporate-governance as well as under its profile on SEDAR+ (www.sedarplus.ca). The mailing of the Circular and related materials for the Meeting to shareholders as of the record date on June 16, 2025, has been completed.
Aurora Cannabis Inc. (ACB) Announces Filing and Mailing of the Management Information
Neutral
PRNewsWire
2 days ago
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders
Your vote is important no matter how many shares you own. Please vote today.
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Special Meeting of Shareholders
Positive
Seeking Alpha
6 days ago
Americans Should Buy Canadian Cannabis Companies
Canadian LPs offer compelling risk/reward versus U.S. cannabis stocks, with stronger balance sheets, tangible book value, and global opportunities due to federal legality. Despite recent rallies, Canadian LPs remain cheap on enterprise value to EBITDA, especially Village Farms, Organigram, and Tilray Brands, which I hold in my model portfolio. U.S. MSOs face significant risks from 280E tax liabilities and negative tangible equity, making Canadian LPs a safer bet for cannabis investors right now.
Americans Should Buy Canadian Cannabis Companies
Neutral
PRNewsWire
1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
NEW YORK , July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc.  ("Aurora Cannabis" or the "Company") (NASDAQ: ACB).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
Neutral
PRNewsWire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ: ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
Neutral
PRNewsWire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc.  ("Aurora Cannabis" or the "Company") (NASDAQ: ACB).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
Neutral
PRNewsWire
2 weeks ago
Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program
Canada's Largest Medical Cannabis Company Offers the Country's Most Inclusive Medical Cannabis Pricing Program NASDAQ | TSX: ACB EDMONTON, AB , June 26, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to have recently expanded eligibility of their medical compassionate pricing program in Canada. As part of the company's ongoing commitment to making medical cannabis more accessible to patients, the yearly income eligibility of the program has increased from $40,000 to $60,000 CAD for Aurora patients through AuroraMedical.com.
Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program
Neutral
PRNewsWire
2 weeks ago
Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products
Proprietary Genetics to be the Highest Potency Medical Cannabis Products Available on the Market NASDAQ | TSX: ACB EDMONTON, AB , June 24, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of two new proprietary cultivars in Poland, marking the highest potency medical cannabis products available in the country. Grown and manufactured in the company's Canadian GACP and EU-GMP facilities, the premium dried medical cannabis products Farm Gas and Sourdough are crafted with precision and expertise to deliver a superior, high THC flower.
Aurora Sets New Standard in Poland with the Launch of Two High Potency Flower Products
Negative
Seeking Alpha
2 weeks ago
Aurora Cannabis Falls On Weak 2026 Outlook Despite Record Q4 Revenues
Aurora Cannabis recently reported improved Q4-2025 results. ACB's international medical cannabis sales are increasing revenues. The company reported record revenues, but low gross profit and weak 2026 outlook.
Aurora Cannabis Falls On Weak 2026 Outlook Despite Record Q4 Revenues
Neutral
MarijuanaStocks
3 weeks ago
3 Cannabis Stocks For Investors To Secure For Future Gains
The current state of the cannabis sector has people feeling a type of way. To be more descriptive, those who are invested in marijuana stocks are feeling the backlash of the market. For some time, there has been a sharp decline in the overall trading for most top marijuana stocks. Now, you would think that with the sector down and showing no true signs of recovery, all is lost. That is not the case, as most companies are making money and having a positive impact.
3 Cannabis Stocks For Investors To Secure For Future Gains
Charts implemented using Lightweight Charts™